iOS
Android
Facebook
WhatsApp
Twitter
RIVAXORED (Rivaroxaban) 20 mg Tablets Bioequivalence: Bioequivalent to the innovator (Xarelto®) — comparative bioavailability data on file. Description: Oral factor Xa inhibitor. Uses: NVAF—prevention of stroke/systemic embolism; continued treatment and prevention of recurrent DVT/PE after the initial 3-week phase. Ingredients: Rivaroxaban 20 mg (film-coated tablet). How to use: 20 mg once daily with food. (For extended VTE prevention after ≥6 months, some patients may use 10 mg once daily if clinician directs.) Precautions (key only): Bleeding risk; avoid with hepatic disease with coagulopathy.
KES 2,447.00
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
